Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (851-865)

Previous 50

851. MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response. Lee DJ, Preble J, Lee S, Foster CS, Taylor AW. Scientific Reports. 2016;6:37790

852. A review of the ocular manifestations of rheumatoid arthritis. Lamba N, Lee S, Chaudhry H, Foster CS. Cogent Medicine. 2016; 3:1243771

853. Risk of Retinal Neovascularization in Cases of Uveitis. Patel AK, Newcomb CW, Liesegang TL, Jujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Nida Sen H, Artornsombudh P, Srishti Kothari, Kempen JH.  American Academy of Ophthalmology. 2016;123:646-654

854. Successful Treatment Strategies in Granulomatosis With Polangiitis-Associated Peripheral Ulcerative Keratitis. Ebrahimiadib N, Modjtahedi BS, Roohipoor R, Anesi SA, Foster CS. Cornea. 2016 November; 35(11):1459-1465

855. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes. Abu Samra K, Oray M, Ebrahimiadib N, Lee S, Anesi SD, Foster CS.  Ocular Immunology and Inflammation. 2016; 00(00):1-6

856. Matei VM, Cao JH, Foster CS. Bilateral Hypopyons as a Presenting Symptom. JAMA Ophthalmology. 2016 December; 134(12):1439-1440

857. Long-Term Drug-Free Remission and Visual Outcomes in Sympathetic Ophthalmia. Payal A, Foster CS. Ocular Immunology and Inflammation. 2016; 00(00):1-6

858. Current Treatment Modalities JIA-associated Uveitis and its Complications: Literature Review. Abu Samra K, Maghsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS.  Ocular Immunology and Inflammation. 2016; 00(00):1-9

859. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab. Abu Samra K, Valdes-Navarro M, Lee S, Swan R, Foster CS, Anesi SD. European Journal of Ophthalmology. 2015.

860. Progress in the Understanding and Utilization of Biologic Response Modifiers in the Treatment of Uveitis. Maleki A, Meese H, Sahawneh HF, Foster CS.  Expert Review of Clinical Immunology. 2016.

861. Long Term Outcomes of Rituximad Therapy in Patients with Noninfectious Posterior Uveitis Refractory to Conventional Immunosuppressive Therapy. Lasave AF, You C, Ma L, Abusamra K, Lamba N, Navarro MV, Meese H, Foster CS.  Retina. 2017; 0:1-8

862. Bilateral Herpes Simplex Uveitis : Review of the Literature and Own Reports. De-la-Torre A, Valdes-Camacho J, Foster CS. Ocular Immunolody & Inflammation. 2016;00(00):1-6

863. Foster CS. Take the stepladder approach to uveitis. Ophthalmology Management. 2016 August.

864. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region. Ahmed AH, Foster CS, Shields CL. JAMA Ophthalmology. 2017 September 7

865. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study. You C, Lamba N, Lasave AF, Ma L, Diaz MH, Foster CS.  Graefe’s Archive for Clinical and Experimental Ophthalmology. 2017 Feb 3:1-8.

Previous 50

  • Online Physician Forum

    Our Online Physician Forum is currently under development. Please check back periodically.
  • Twitter Feed